Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

BACKGROUND: Glycopyrronium tosylate (GT) is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years. GT was evaluated for primary axillary hyperhidrosis in replicate, randomized, double-blind, vehicle-controlled, phase III trials. GT reduced sweati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariser, David M., Hebert, Adelaide A., Drew, Janice, Quiring, John, Gopalan, Ramanan, Glaser, Dee Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516143/
https://www.ncbi.nlm.nih.gov/pubmed/30378087
http://dx.doi.org/10.1007/s40257-018-0395-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516143/
https://www.ncbi.nlm.nih.gov/pubmed/30378087
http://dx.doi.org/10.1007/s40257-018-0395-0

Ejemplares similares